A Multi-Center, Open-Label, Follow-on Trial to Assess the Long-Term Safety and Efficacy of Lacosamide in Subjects With Painful Distal Diabetic Neuropathy Including a Double-Blind, Randomized Time Point Withdrawal Subtrial.

Trial Profile

A Multi-Center, Open-Label, Follow-on Trial to Assess the Long-Term Safety and Efficacy of Lacosamide in Subjects With Painful Distal Diabetic Neuropathy Including a Double-Blind, Randomized Time Point Withdrawal Subtrial.

Completed
Phase of Trial: Phase III

Latest Information Update: 30 Aug 2017

At a glance

  • Drugs Lacosamide (Primary)
  • Indications Diabetic neuropathies; Neuropathic pain
  • Focus Adverse reactions
  • Sponsors Pharma Schwarz; UCB
  • Most Recent Events

    • 08 Jan 2010 Planned end date changed from 1 Dec 2009 to 1 Dec 2010 as reported by ClinicalTrials.gov.
    • 18 Nov 2009 Additional trial location identified as Finland as reported by ClinicalTrials.gov.
    • 18 Apr 2009 UCB added as trial sponsor and trial affiliate as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top